Hunan Dajiaweikang Pharmaceutical Industry: Announcement Regarding Change of Business Scope of Wholly-Owned Subsidiary and Completion of Industrial and Commercial Change Registration.
Hunan Dajiaweikang Pharmaceutical Industry: Legal Opinion of Hunan Qiyuan Law Firm on the 2023 Annual General Meeting of Shareholders of Hunan Dajia Weikang Pharmaceutical Industry Co., Ltd.
Hunan Dajiaweikang Pharmaceutical Industry: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Dajia Weikang: Summary table on the use of non-operating capital and other related capital transactions in 2023
Dajia Weikang: Notice on Convening the 2023 Annual General Meeting of Shareholders
Dajia Weikang: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Dajia Weikang: Announcement on the 2024 Remuneration Plan for Directors, Supervisors and Senior Managers
Dajia Weikang: Announcement on 2023 Credit Impairment Preparation and Asset Impairment Preparation
Dajia Weikang: 2023 Internal Control Evaluation Report
Dajia Weikang: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Dajia Weikang: Legal Opinion of Hunan Qiyuan Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Hunan Dajia Weikang Pharmaceutical Industry Co., Ltd.
Dajia Weikang: Announcement on the situation where securities regulators and exchanges have not taken regulatory measures or penalties in the last five years
Dajia Weikang: Notice on Convening the Third Extraordinary General Meeting of Shareholders in 2024
Dajia Weikang: Announcement on requesting the shareholders' meeting to approve the exemption of the controlling shareholder from increasing the company's shares through an offer
Dajia Weikang: Announcement on signing conditionally effective share subscription contracts with specific targets
Dajia Weikang: Announcement on completing the registration of industrial and commercial changes and issuing a business license
Dajia Weikang: Legal Opinion of Shanghai Tongli Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Hunan Dajia Weikang Pharmaceutical Industry Co., Ltd.
Dajia Weikang: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Dajia Weikang: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Dajia Weikang: Legal Opinion of Shanghai Tongli Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Hunan Dajia Weikang Pharmaceutical Industry Co., Ltd.
No Data